Learn More
Correction After the publication of this work [1], we noticed that we had incorrectly used the term 'OGX-011'. All instances of OGX-011 in the manuscript should be changed to ' ASO-CLU'. We apologise to the readers and OncoGenex Technologies for this oversight and any negative effects that may have resulted from it. which permits unrestricted use,(More)
OBJECTIVE To measure clusterin expression in pancreatic cancer tissues and cell lines and to evaluate whether clusterin confers resistance to gmcitabine in pancreatic cancer cells. METHODS Immunohistochemistry for clusterin was performed on 50 primary pancreatic cancer tissues and 25 matched backgrounds, and clusterin expression in 5 pancreatic cancer(More)
  • 1